M. John Siebert's Insider Trades & SAST Disclosures
M. John Siebert's most recent trade in Supernus Pharmaceuticals Inc was a trade of 3,886 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 23, 2024.
Add Superstar Alert
Note
This is a custom search result for pattern M. John Siebert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc
|
M. John Siebert | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 0 | - | - | Restricted Stock Unit | |
|
Supernus Pharmaceuticals Inc
|
M. Siebert John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 87,943 (0%) | 0% | 0 | Common Stock | |
|
Supernus Pharmaceuticals Inc
|
M. John Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
|
Supernus Pharmaceuticals Inc
|
M. Siebert John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 6,293 | 6,293 | - | - | Director Stock Option (Right to Buy) | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,886 | 3,886 | - | - | Restricted Stock Units | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 0 | - | - | Restricted Stock Units | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 84,057 (0%) | 0% | 0 | Common Stock | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 6,847 | 6,847 | - | - | Director Stock Option (Right to Buy) | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,882 | 3,882 | - | - | Restricted Stock Units | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 80,175 (0%) | 0% | 0 | Common Stock | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 0 | - | - | Restricted Stock Units | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 11 Aug 2021 | 15,000 | 75,953 (0%) | 0% | 13.0 | 194,700 | Common Stock |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 15,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 7,365 | 7,365 | - | - | Director Stock Option (Right to Buy) | |
|
Supernus Pharmaceuticals Inc
|
John M. Siebert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 4,222 | 4,222 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges